Gland Pharma Future Growth
Future criteria checks 3/6
Gland Pharma is forecast to grow earnings and revenue by 19.6% and 9.9% per annum respectively. EPS is expected to grow by 19.6% per annum. Return on equity is forecast to be 12.2% in 3 years.
Key information
19.6%
Earnings growth rate
19.6%
EPS growth rate
| Pharmaceuticals earnings growth | 16.9% |
| Revenue growth rate | 9.9% |
| Future return on equity | 12.2% |
| Analyst coverage | Good |
| Last updated | 28 May 2024 |
Recent future growth updates
Recent updates
Earnings Miss: Gland Pharma Limited Missed EPS By 15% And Analysts Are Revising Their Forecasts
May 25
Is Gland Pharma (NSE:GLAND) A Risky Investment?
Mar 19Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion
Feb 16Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher
May 20Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value
Feb 07Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers
Jul 22Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?
Jul 14Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?
Feb 08A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)
Jul 05Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues
May 24Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
May 19Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings
Mar 04Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 20Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 79,210 | 13,514 | 9,404 | 12,199 | 4 |
| 3/31/2026 | 70,790 | 12,430 | 9,358 | 10,188 | 10 |
| 3/31/2025 | 63,998 | 9,528 | 2,662 | 12,556 | 7 |
| 3/31/2024 | 58,350 | 7,725 | 5,985 | 9,968 | N/A |
| 12/31/2023 | 49,123 | 6,587 | N/A | N/A | N/A |
| 9/30/2023 | 43,054 | 6,988 | 832 | 3,901 | N/A |
| 6/30/2023 | 39,764 | 7,460 | N/A | N/A | N/A |
| 3/31/2023 | 36,246 | 7,810 | 1,408 | 3,640 | N/A |
| 12/31/2022 | 39,426 | 9,883 | N/A | N/A | N/A |
| 9/30/2022 | 40,676 | 10,293 | 6,747 | 9,508 | N/A |
| 6/30/2022 | 41,037 | 10,902 | N/A | N/A | N/A |
| 3/31/2022 | 44,007 | 12,117 | 2,687 | 7,908 | N/A |
| 12/31/2021 | 41,854 | 11,862 | N/A | N/A | N/A |
| 9/30/2021 | 39,815 | 11,172 | 328 | 4,688 | N/A |
| 6/30/2021 | 37,326 | 10,340 | N/A | N/A | N/A |
| 3/31/2021 | 34,629 | 9,970 | 3,762 | 6,049 | N/A |
| 12/31/2020 | 32,104 | 9,313 | N/A | N/A | N/A |
| 6/30/2020 | 28,430 | 9,027 | 7,025 | 9,058 | N/A |
| 3/31/2020 | 26,332 | 7,729 | 5,063 | 7,009 | N/A |
| 3/31/2019 | 20,442 | 4,519 | 495 | 1,853 | N/A |
| 3/31/2018 | 16,199 | 3,211 | 1,169 | 2,021 | N/A |
| 3/31/2017 | 14,792 | 4,137 | N/A | 4,765 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GLAND's forecast earnings growth (19.6% per year) is above the savings rate (6.7%).
Earnings vs Market: GLAND's earnings (19.6% per year) are forecast to grow faster than the Indian market (15.8% per year).
High Growth Earnings: GLAND's earnings are forecast to grow, but not significantly.
Revenue vs Market: GLAND's revenue (9.9% per year) is forecast to grow faster than the Indian market (9.5% per year).
High Growth Revenue: GLAND's revenue (9.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GLAND's Return on Equity is forecast to be low in 3 years time (12.2%).